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Bacteriological diagnosis of brucellosis is performed by culturing animal samples directly on both Farrell
medium (FM) and modified Thayer-Martin medium (mTM). However, despite inhibiting most contaminating
microorganisms, FM also inhibits the growth of Brucella ovis and some B. melitensis and B. abortus strains. In
contrast, mTM is adequate for growth of all Brucella species but only partially inhibitory for contaminants.
Moreover, the performance of both culture media for isolating B. suis has never been established properly. We
first determined the performance of both media for B. suis isolation, proving that FM significantly inhibits B.
suis growth. We also determined the susceptibility of B. suis to the antibiotics contained in both selective media,
proving that nalidixic acid and bacitracin are highly inhibitory, thus explaining the reduced performance of
FM for B. suis isolation. Based on these results, a new selective medium (CITA) containing vancomycin,
colistin, nystatin, nitrofurantoin, and amphotericin B was tested for isolation of the main Brucella species,
including B. suis. CITA’s performance was evaluated using reference contaminant strains but also field
samples taken from brucella-infected animals or animals suspected of infection. CITA inhibited most con-
taminant microorganisms but allowed the growth of all Brucella species, to levels similar to those for both the
control medium without antibiotics and mTM. Moreover, CITA medium was more sensitive than both mTM
and FM for isolating all Brucella species from field samples. Altogether, these results demonstrate the adequate
performance of CITA medium for the primary isolation of the main Brucella species, including B. suis.
Brucellosis is a worldwide zoonosis affecting mainly low-
income countries (23). Besides two new species (Brucella ceti
and B. pinnipedialis) isolated recently from marine mammals,
the genus Brucella includes six classical species named accord-
ing to their host preference (18). Among them, B. melitensis, B.
abortus, B. suis, and B. ovis (which preferentially infect sheep
and goats, cattle, pigs, and sheep, respectively) are the most
important from a socioeconomic standpoint, since in addition
to decreasing productivity in animals, the first three species are
the main ones responsible for brucellosis in human beings (19).
In infected animals, brucellae can be isolated from vaginal
discharges, placental and fetal tissues, milk, and semen of live
animals and, after necropsy, from the lymph nodes, spleen,
liver, mammary glands, epididymides, and male sexual glands.
Due to its specificity, the isolation and identification of Brucella
in these animal fluids and tissues are the only incontestable
demonstration of brucellosis in a given animal or flock. Since
primary Brucella isolation requires 4 to 7 days of incubation,
the presence in the above field samples of overgrowing fungi as
well as commensal and environmental bacteria explains the
frequent contamination of culture plates and the reduced sen-
sitivity of bacteriological diagnosis. Thus, the use of adequate
selective culture media is of paramount importance for a
proper bacteriological diagnosis of brucellosis.
The simultaneous use of Farrell’s medium (FM) (7) and
modified Thayer-Martin medium (mTM) (15) is currently con-
sidered the strategy of choice for primary Brucella isolation
from field veterinary samples (21). FM is probably the most
widely used selective medium for the bacteriological diagnosis
of brucellosis. This excellent medium, initially developed for
the isolation of B. abortus bv. 2 from contaminated sources (6,
7), contains antibiotics that are highly inhibitory for most over-
growing contaminants present in field veterinary samples (14).
Moreover, because it is translucent, it facilitates the presump-
tive identification of Brucella by assessing the colony morphol-
ogy (1). However, due mainly to the nalidixic acid and baci-
tracin contained in its formulation, FM is inhibitory for B. ovis
and also for some B. melitensis and B. abortus strains (15).
Considering that mTM significantly improves the sensitivity of
FM for the isolation of B. ovis and B. melitensis (3, 14), the
simultaneous use of both culture media has been recom-
mended for the routine bacteriological diagnosis of disease
(21). However, mTM is significantly less inhibitory than FM for
contaminant microorganisms. Moreover, mTM is not translu-
cent due to the presence of hemoglobin as a basal component
and thus is unsuitable for direct observation of colony mor-
phology, probably the most practical procedure for the pre-
sumptive identification of Brucella (1). Finally, the perfor-
mance of both FM and mTM for isolating B. suis has been the
object of debate but has never been investigated thoroughly.
One of the objectives of this work was to evaluate this subject
and to investigate the susceptibility of B. suis to the different
antibiotics contained in both selective media. Using the results
obtained, we formulated a new selective culture medium
(CITA medium) which, in addition to being translucent, allows
the growth of all Brucella species and simultaneously inhibits
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most contaminant microorganisms present in veterinary sam-
ples.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and medium compositions. The Brucella
reference and field strains used are summarized in Table 1. All Brucella strains
were typed by standard bacteriological (1) and molecular (8) procedures and
were kept lyophilized at 4°C in the culture collection of the CITA de Arago´n
(Zaragoza, Spain) until use. After rehydration, the strains were cultured on
blood agar base plates (BAB no. 2; Biolife, Italy) supplemented with 5% sterile
newborn calf serum (CS; PanBiotech, Germany) (BAB-CS) as described previ-
ously (9). Brucella suspensions were prepared in sterile buffered saline solution
(BSS; pH 6.85) and adjusted to the desired concentration by spectrophotometry
(suspensions with an optical density at 600 nm [OD600] of 0.170 usually contain
1  109 CFU/ml), using BSS or Mueller-Hinton broth (MHB; Difco) supple-
mented with 0.5% yeast extract (YE; Difco) and 5% CS (MHB-YE-CS). The
exact number of colonies (CFU/ml) contained in each bacterial suspension was
determined retrospectively, as described elsewhere (9).
The microorganisms used as typical contaminants of veterinary samples were
Escherichia coli (ATCC 285922), Staphylococcus aureus (ATCC 6538), Aspergillus
niger (ATCC 16404), Bacillus subtilis (ATCC 6633), Enterococcus faecalis (ATCC
29212),Pseudomonas aeruginosa (ATCC 27853), andProteus spp. (MicroBioLogics). All
of these strains were provided by the Spanish Type Culture Collection (ECCT;
University of Valencia, Spain) and cultured as recommended by the supplier.
The growth or inhibition of these contaminant microorganisms on the corre-
sponding selective culture media was assessed after 1 week of incubation at 37°C
in both air and a 10% CO2 atmosphere.
Both FM and mTM were prepared as described previously (15), and the
compositions of these media are shown in Table 2.
Susceptibility of B. suis to both FM and mTM. Bacterial suspensions of the 5
B. suis reference strains and 40 field strains tested (Table 1) were prepared in
BSS, and dilutions containing around 1  103 CFU/ml were cultured (0.1 ml/
plate) in triplicate on plates of FM, mTM, and BAB-CS (control). The mean and
standard deviation (SD) for the number of CFU/plate were determined for each
strain in each culture medium after incubation of plates at 37°C for 3 days in a
10% CO2 atmosphere. In addition, the 40 B. suis field strains were also studied
for individual susceptibilities to each of the 9 antimicrobial agents contained in
both FM and mTM, as well as to amphotericin B (Sigma Aldrich) (Table 2). This
experiment was carried out in both liquid and solid media, as follows.
(i) Liquid medium assay. Bacterial suspensions of the above-mentioned B. suis
strains in MHB-YE-CS were adjusted to 5  105 CFU/ml as described above,
and 0.1 ml of each suspension was mixed in a 96-well sterile plate (Nunc micro-
plate; ThermoFisher Scientific S.L.U., Spain) with 0.1 ml of MHB-YE-CS sup-
plemented with adequate antibiotic concentrations. For this purpose, concen-
trated suspensions of each antibiotic were prepared in MHB-YE-CS (40 mg/liter
nalidixic acid, 200,000 IU/liter bacitracin, 40,000 IU/liter polymyxin B, 800 mg/
liter cycloheximide, 400 mg/liter natamycin, 800,000 IU/liter nystatin, 160 mg/
liter vancomycin, 60 mg/liter colistin, 80 mg/ml nitrofurantoin, and 32 mg/liter
amphotericin B) (all from Sigma Aldrich) and then 2-fold serially diluted in
MHB-YE-CS. Wells containing only bacteria, antibiotics, or MHB-YE-CS were
used as controls in each plate. Plates were incubated at 37°C in 10% CO2, and
bacterial growth was determined spectrophotometrically (OD595 readings) 4 and
7 days after incubation and confirmed by streaking out 25 l/well in triplicate
onto BAB-CS plates, which were incubated at 37°C in 10% CO2 for 5 to 7 days.
Isolation of at least one CFU was considered a positive result.
(ii) Solid medium assay. Bacterial suspensions of the above-mentioned B. suis
strains were adjusted in BSS to 1  103 CFU/ml, and 0.1 ml of each suspension
was smeared in triplicate on MH agar plates (MHA; Difco) supplemented with
YE-CS as described above (MHA-YE-CS) and supplemented or not with the
corresponding concentration of each antibiotic (Table 2). Nalidixic acid and
bacitracin (both from Sigma Aldrich) were also tested at concentrations 2-fold
above those contained in FM. The mean number of CFU/plate for each culture
medium was determined after incubation at 37°C for 5 to 7 days in a 10% CO2
atmosphere. The mean (n 3) individual number of CFU/plate was assessed for
each Brucella strain in each culture medium. Once equivalent numbers of CFU
were obtained in the control BAB-CS medium for the 45 B. suis strains tested,
the mean and SD for the number of CFU/plate were determined for each
antimicrobial agent. Statistical comparisons of means were performed by a two-
way (strain-medium interaction) analysis of variance (ANOVA) followed by post
hoc Fisher’s protected least significant difference (PLSD) test.
Development of new selective culture medium (CITA). Considering the im-
portance and practical interest of using translucent media, the performances of
the following basal culture media were assessed for isolating the main Brucella
species: brucella medium base (BMB; Oxoid, United Kingdom), GC medium
base (GC; Difco), Trypticase soy broth supplemented with 0.5% yeast extract
(both products from Biolife, Italy) and 1.5% agar (Difco) (TSA-YE), and BAB.
All of these basal components were supplemented with 5% sterile CS, and the
resulting culture media (BMB-CS, GC-CS, TSA-YE-CS, and BAB-CS) were
TABLE 1. Brucella reference and field strains used in this work
Species Biovara Strain
No. of
strains or
isolates
Reference strains
B. abortus 1 2308
1 S19
3 Tulya
B. melitensis 1 16 M
1 Rev1
2 63/9
3 Ether
B. suis 1 1330
2 Thomsen
3 680
4 40
5 513
B. ovis NA Bow
NA Reo 198
B. canis NA 6/66
Strains isolated from field samples
B. abortus 1 S19 2
1 RB51 26
3 7
B. melitensis 1 61
3 148
1 Rev1 28
B. suis 1 5
2 25
3 7
4 3
B. ovis NA 32
a NA, not applicable.
TABLE 2. Compositions of the selective culture media compared
in this study
Component
Concn or descriptiona
FM mTM CITA
Basal medium BMB-CS GC-H BAB-CS
Nalidixic acid (mg/liter) 5
Bacitracin (IU/liter) 25,000
Polymyxin B (IU/liter) 5,000
Cycloheximide (mg/liter) 100
Natamycin (mg/liter) 50
Vancomycin (mg/liter) 20 3 20
Nystatin (IU/liter) 100,000 100,000 100,000
Colistin (mg/liter) 7.5 7.5
Nitrofurantoin (mg/liter) 10 10
Amphotericin B (mg/liter) 4
a FM, Farrell’s medium (7); BMB-CS, brucella medium base (Oxoid, United
Kingdom) supplemented with 5% CS (PanBiotech, Germany); mTM, modified
Thayer-Martin medium (15); GC-H, GC agar base supplemented with 2 g Bacto
agar and 1% hemoglobin (all from Difco); CITA, new selective culture medium;
BAB-CS, blood agar base number 2 (Biolife, Italy) supplemented with 5% CS.
FM was prepared using commercial antibiotic supplements containing either
natamycin or cycloheximide (Oxoid). All antimicrobial agents not included in the
commercial FM supplements were from Sigma.
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compared for Brucella growth. Adjusted suspensions (see above) of representa-
tive B. abortus, B. melitensis, B. suis, and B. ovis strains (Table 1) were plated in
the corresponding basal media and incubated for 5 to 7 days at 37°C in 10% CO2,
and the resulting mean CFU/plate was determined as described elsewhere (9).
With the exception of GC-CS, which was somewhat inhibitory, the remaining
media performed similarly for isolation of all Brucella species (results not
shown). With its adequate performance and availability, BAB-CS was considered
the basal component of choice for ensuing experiments.
In the second experimental phase, suspensions of representative Brucella
strains (Table 1) and contaminants were inoculated on BAB-CS plates supple-
mented with all of the antibiotics contained in mTM (Table 2), but increasing the
vancomycin (Sigma Aldrich) concentration to 20 mg/liter (as in FM) and adding
several concentrations (2.5, 4, and 5 mg/liter) of amphotericin B (Sigma Aldrich)
as a complementary antifungal agent. The same mTM formulation without
amphotericin B (Sigma Aldrich) and BAB-CS alone were used as controls in this
experiment. The resulting CFU of the corresponding contaminants and brucellae
were determined in triplicate experiments after incubation at 37°C in 10% CO2
for 3 and 5 days, respectively.
According to the results obtained in these previous experiments, 4 mg/liter of
amphotericin B (Sigma Aldrich) and 20 mg/liter of vancomycin (Sigma Aldrich)
were considered adequate enough to inhibit the contaminant microorganisms
while allowing the growth of all Brucella species and strains tested. Thus, the
CITA medium was formulated with BAB-CS as a basal component and with the
following antibiotic supplements: vancomycin (20 mg/liter), colistin methanesul-
fonate (7.5 mg/liter), nitrofurantoin (10 mg/liter), nystatin (100,000 IU/liter), and
amphotericin B (4 mg/liter) (all from Sigma Aldrich).
Diagnostic performance of CITA medium. The performance of the new selec-
tive culture medium was compared with those of both FM and mTM, using
representative reference and field strains (i.e., 38 B. abortus, 35 B. melitensis, 45
B. suis, and 34 B. ovis strains). Adequate suspensions of these strains were
cultured in triplicate, and the numbers of CFU per plate in each selective
medium and in BAB-CS as a control were determined and statistically compared
as described previously (9). Also, the growth or inhibition of contaminant mi-
croorganisms was determined for each culture medium after 72 h of incubation
at 37°C in a 10% CO2 atmosphere.
In the final step, the performance of CITA medium for direct primary isolation
was compared to those of FM and mTM, with the last being supplemented with
4 mg/liter of amphotericin B (Sigma Aldrich) (mTMA). For this purpose, a total
of 4,483 fresh field samples were obtained either in vivo (milk, vaginal swabs, and
semen) or after necropsy (uterus/epididymides, spleen, and lymph nodes) from
(i) rams experimentally infected with B. ovis PA (n  528 samples), (ii) sheep
suspected of B. melitensis infection (n  3,247 samples), (iii) swine suspected of
B. suis infection (n  602 samples), and (iv) aborted cattle in an area where B.
abortus is endemic and cattle are vaccinated with B. abortus RB51 (n  106
samples) (see Table 4). All of these samples were taken and processed as
described previously (2), and the same sample amounts (massively in the case of
vaginal swabs and 0.5 ml of tissue homogenate/plate for the remaining samples)
were cultured in duplicate plates of CITA and either mTMA or FM (see Table
4). One culture was considered positive when at least one CFU of Brucella was
isolated. The suspected Brucella colonies isolated were identified and typed using
both standard microbiological (1) and molecular (8) methods. The number of
contaminated plates of each selective medium was also recorded.
RESULTS
B. suis studies. The mean  SD (n  45) CFU/plate ob-
tained with representative B. suis strains in FM (11.3  5.7)
was significantly lower (P  0.0001) than those obtained with
both mTM (69.4  21) and BAB-CS (69.3  20). The liquid
medium assay evidenced that all B. suis strains were highly
susceptible to nalidixic acid and bacitracin at concentrations
close to and above those contained in FM (data not shown).
These results correlated with those obtained in the solid me-
dium assays (Table 3), in which the number of B. suis CFU was
significantly inhibited (P  0.001) by both antibiotics at the
concentrations used in FM and at 2-fold higher concentrations
(Table 3). In contrast, the remaining antibiotics tested did not
show significant inhibitory effects on B. suis.
Development and performance of CITA selective medium.
B. suis bv. 2 strains were significantly (P  0.0001) inhibited
when they were cultured on GC-CS basal medium (not shown).
However, when hemoglobin was added to this basal medium,
all B. suis strains grew as in BAB-CS (not shown). Although
the difference was not significant, the BMB-CS basal medium
negatively affected the growth of B. ovis (not shown). Thus,
both media were discarded as basal components for formulat-
ing the new CITA medium. In contrast, both BAB-CS and
TSA-YE-CS media showed similar performances (in terms of
CFU numbers and colonial morphology and size) in support-
ing the growth of all Brucella species (not shown). For practical
reasons, availability, and ease of preparation, BAB-CS was
selected as the basal medium for CITA formulation.
The antibiotics contained in mTM (Table 2) allowed the
growth of A. niger and E. faecalis while inhibiting the remaining
contaminant microorganisms tested (not shown). However, A.
niger was inhibited when 4 or 5 mg/liter (but not 2.5 mg/liter)
of amphotericin B was added to either mTM or BAB-CS (not
shown). Moreover, E. faecalis growth was fully inhibited when
20 mg/liter (but not lower concentrations) of vancomycin was
added to either mTM or BAB-CS. Therefore, in addition to
the antibiotics contained in mTM (Table 2), amphotericin B (4
mg/liter) and vancomycin (20 mg/liter) were selected as the
antibiotic combination of choice for the definitive formulation
of the new CITA selective medium.
The comparative efficacies of mTM, FM, and CITA medium
to support the growth of the different Brucella species and
biovars are shown as a box-plot graph in Fig. 1. Boxes repre-
sent the two central quartiles, the data between whiskers are
90% of the data obtained for each Brucella species (Table 1) in
each culture medium, and horizontal lines inside boxes indi-
cate the median values (CFU/plate) obtained. As expected,
FM fully inhibited the growth of B. ovis and significantly re-
duced the growth of B. suis and B. melitensis (P  0.0001), as
well as that of some strains of B. abortus (not evident in Fig. 1),
with respect to that on BAB-CS control medium. Moreover,
TABLE 3. Susceptibility of B. suis to the different antibiotics
contained in FM and mTM
Antibiotic Concn Growth of B. suis(no. of CFU/plate mean  SD)a
Nalidixic acid 5 mg/liter 71.7  8.1*
10 mg/liter 2.9  0.6**
Bacitracin 25,000 IU/liter 70.9  6.9*
50,000 IU/liter 13.8  3.7**
Polymyxin B 5,000 IU/liter 81.4  7.9
Cycloheximide 100 mg/liter 80.8  7.5
Natamycin 50 mg/liter 78.8  7.3
Vancomycin 20 mg/liter 74.3  9.8
Nystatin 100,000 IU/liter 80.1  7.7
Colistin 7.5 mg/liter 79.6  7.9
Nitrofurantoin 10 mg/liter 80.7  8.1
Amphotericin B 4 mg/liter 80.7  6.6
None (control) 80.5  7.8
a Growth of 40 representative B. suis strains (Table 1) in MHA-YE-CS sup-
plemented with the indicated antibiotics at the concentrations used in FM or
mTM. Nalidixic acid and bacitracin were also tested at 2-fold higher concentra-
tions than those in FM or mTM. , P  0.001; , P  0.0001 with respect to
MHA-YE-CS agar control plates without the corresponding antibiotic.
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both CITA medium and mTM were as effective as BAB-CS
medium without added antibiotics at supporting the growth of
all Brucella species and biovars tested (Fig. 1). In testing the
ability of these culture media to inhibit the growth of contam-
inants, both FM and CITA medium fully inhibited the stan-
dard contaminant microorganisms tested, while mTM allowed
the growth of A. niger and E. faecalis (results not shown).
The comparative diagnostic performances of the three
selective culture media for isolating Brucella from field sam-
ples are summarized in Table 4. The number of culture
plates discarded due to the presence of overgrowing con-
taminants was lower for CITA medium than for mTM for
samples from B. ovis-exposed rams but was similar to that
for FM for the remaining samples. Regardless of the Bru-
cella species considered, the new CITA medium showed a
higher overall diagnostic sensitivity than the other selective
media compared (Table 4).
DISCUSSION
The use of selective culture media is needed to increase the
probability of success of bacterial culture, and it is compulsory
for the adequate bacteriological diagnosis of brucellosis. The
different studies conducted with the several selective culture
media described until now (1, 3, 5, 7, 10, 11, 12, 13, 15, 16, 22,
24, 25, 26, 27) have concluded that the simultaneous use of
both FM and mTM results in maximal sensitivity to isolate the
most relevant Brucella species and biovars from field veterinary
samples (21). FM is probably the most widely used selective
medium for isolating Brucella, as it inhibits most contaminants
FIG. 1. Growth (number of CFU/plate) of representative Brucella species (see Table 1 for descriptions) on BAB-CS and three selective culture
media: mTM (15), FM (15), and CITA (the new selective medium developed in this work). Statistical comparisons of means (numbers of
CFU/plate) obtained for a given Brucella sp. for the different culture media were performed by Fisher’s PLSD test. *, P  0.0001 between FM and
any other culture medium.
TABLE 4. Numbers of animal samples cultured in CITA and either FM or mTMA and the corresponding Brucella sp. strains isolateda
Brucella organism(s) detected
(no. of isolates)
No. of
samples
cultured
No. of Brucella strains isolated (no. of contaminated plates)
CITA
alone
FM
alone
mTMA
alone
Both FM
and mTM Total
B. ovis 528b 93 (0) ND 50 (22) 151 (10) 294 (32)
B. melitensis bv. 1 strain Rev1 (28), field strains (331), and bv. 3 (139) 3,247c 157 (37) 39 (45) ND 302 (19) 498 (101)
B. suis bv. 2 602d 46 (22) 16 (14) ND 49 (11) 111 (47)
B. abortus bv. 1 strains S19 (1) and RB51 (24) and bv. 3 (7) 106e 11 (21) 0 (13) ND 21 (10) 32 (44)
a See Table 2 for the exact composition of each selective culture medium. mTMA, mTM supplemented with 4 mg/liter of amphotericin B. ND, not determined.
b Semen and necropsy samples from rams experimentally infected with B. ovis PA.
c Vaginal swabs and milk and necropsy samples from sheep suspected of B. melitensis infection.
d Vaginal swabs and milk and necropsy samples from swine suspected of B. suis infection.
e Vaginal swabs and milk samples from cattle from areas where B. abortus is endemic and who were vaccinated with RB51.
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present in field veterinary samples. However, some of the an-
tibiotics contained in this medium are also highly inhibitory for
B. ovis and some B. melitensis and B. abortus strains, including
the RB51 vaccine strain (11, 15). In the cases of B. abortus and
B. melitensis, this inhibitory effect is due mainly to the presence
in FM of nalidixic acid and bacitracin at concentrations close to
or higher than (Table 3) those allowing the growth of all strains
of these Brucella species (15). The results obtained here con-
firm the above findings showing that FM fully inhibits the
growth of B. ovis and significantly reduces the growth of B.
melitensis, and moreover, they demonstrate that it is also highly
inhibitory for B. suis (Fig. 1). Despite a somewhat reduced
growth of B. abortus in FM (Fig. 1), the differences obtained
were not statistically significant in this study.
As indicated above, FM is the preferred culture medium for
the primary isolation of B. abortus from contaminated sources.
Due to the presence of calf serum (7), this medium is very
effective for isolating serum-dependent strains of B. abortus bv.
2 (6, 7). The presence of cycloheximide in the antibiotic sup-
plement makes this medium highly effective for inhibiting the
growth of fungi, which are among the main contaminants
found in field veterinary samples. This agent inhibits the trans-
lation of mRNA by ribosomes, preventing protein synthesis of
fungi. However, this drug has potentially toxic effects on mam-
malian cells, including teratogenesis, DNA damage, birth de-
fects, sperm toxicity, and several others (20). The existence of
these risks has resulted in the increasingly reduced availability
and use of cycloheximide in recent years. Natamycin has been
proposed as an alternative to cycloheximide for inclusion in
commercially available antibiotic supplements for Brucella se-
lective media (26). In fact, an antibiotic supplement containing
natamycin is currently available (Oxoid), although it has been
reported that this drug is somewhat less inhibitory than cyclo-
heximide for fungal growth (26). Amphotericin B has been
proposed as a safer and cheaper antifungal agent and has been
recommended as a component of culture media for the pri-
mary isolation of Mycobacterium spp. (4) and Campylobacter
spp. (17). This drug interacts with ergosterol, a steroid present
in fungal membranes, and results in a loss of both membrane
selective permeability and cytoplasmic components. However,
amphotericin B does not affect bacteria, with the exception of
Mycoplasma species. As demonstrated here, amphotericin B at
4 mg/liter was inhibitory for the reference fungal contaminants
tested but did not affect the growth of B. suis (Table 3) or the
remaining Brucella species tested when it was incorporated
into the new CITA formulation (Fig. 1).
Altogether, the results of the different experiments allowed
us to select the most adequate components to formulate a new
selective medium (CITA) suitable for the isolation of all Bru-
cella species. In addition to a suitable antibiotic combination
(Table 2), this new medium contains BAB-CS as the basal
component, resulting in a translucent medium, which is impor-
tant for facilitating the presumptive identification of brucellae
by assessing colony morphology under stereoscopic magnifica-
tion (1). The addition of serum is also relevant, since this
component allows the growth of the most fastidious Brucella
strains, including B. ovis. These components of the CITA me-
dium were proven highly effective in the final experiment as-
sessing its diagnostic performance on a large collection of
animal field samples (Table 4).
Both FM and mTM have been reported as highly inhibitory
for the B. abortus RB51 vaccine strain (10, 11). Our results
agree with these reports, since FM inhibited over half of the B.
abortus strains isolated, most of which were RB51 (Table 4). In
conclusion, the new CITA selective culture medium should be
considered a useful tool for successful isolation of all Brucella
species from field veterinary samples. However, the simulta-
neous use of CITA plus FM or mTMA results in the best
diagnostic performance for isolating B. melitensis and B. suis or
B. ovis.
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